Journal of Virus Eradication

Article	Citations
Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018	67
OP 5.2 – 00070 Characterization of a dual PTPN1/PTPN2 inhibitor to target latent HIV reservoirs	23
PP 1.33 – 00167 Integrated single-cell multi-omic profiling of HIV latency reversal	18
PP 3.8 – 00137 Characterization of the HIV-1 subtype C reservoir during ART in South-African men and women	14
OP 1.6 – 00138 Role of UHRF1 in HIV-1 transcriptional repression through epigenetic and non-epigenetic mechanisms	13
PP1.19 – 00036 Unexpected Redundancy of the TNF/NF-kB Axis in HIV-1 Restriction and Latency Reversal in Primary Human MDM Polarized to M1 Cells	11
Factors associated with unquantifiable total HIV-1 DNA in peripheral blood in persons living with HIV: An observational study	11
8.2 – 00072 Early intervention with an indoline CD4-mimetic compound that sensitizes HIV-1-infected cells to ADCC favors post-treatment HIV control in humanized mice	10
PP6.5 – 00086 Regulation of AAV transgene expression using nanoparticledelivered Cre-recombinase	10
Editorial JVE 10.2	9
PP5.11 – 00071 A novel in vitro model for studying HIV infection and latency in microglia: SIV Vpx-treated EcoHIV-infected CHME5	9
Impact of hepatitis B vaccination programs in Vietnam evaluated by estimating HBsAg prevalence	9
ST2.4 – 00035 Bach controls seeding of HIV reservoirs in memory CD4+ T cells	9
Langya virus outbreak in China, 2022: Are we on the verge of a new pandemic?	9
Highlights from the virtual conference on retroviruses and opportunistic infections (CROI) 2021: SARS-CoV-2 pathogenesis, new data about antiretroviral treatments, HIV-associated comorbidities, pediat	8
5.5 – 00117 HIV-Tocky system in primary CD4+T cells joined with transcriptomic and epigenomic analysis to discover mechanism involves in the establishment of latency during acute infection	8
PP1.16 – 00059 Identification of solo-LTR HIV provirus in vitro	8
Impact of COVID-19 and intensive care unit capacity on vaccination support: Evidence from a two-leg representative survey in the United Kingdom	7
Highlights of HIV Cure in IAS, Montréal	7
PP 7.8 – 00060 Slowing or Reversal of Decay of Intact Proviruses Over Two Decades of Suppressive ART	6
OP 3.1 HIV Persistence in women, an update	6
PP 2.1 – 00014 Impact of early antiretroviral therapy on tissue resident myeloid cells in the liver and lung of SIV-infected rhesus macaques	6
OP 1.2 – 00157 HIV Silencing and Cell Survival Signatures of HIV-Infected CD4 T Cell Transcriptomes under Antiretroviral Therapy (ART)	5
Editorial JVE 7.3	5
PP6.7 – 00070 Blockade of HIV-1 Latency Reversal in CD4+ T Cells from ARTsuppressed PLWH by the HIV-1 Antisense Transcript AST	4

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral	4
PP2.5 – 00122 The role of Vpr in the epigenetic regulation of HIV-1 latency	4
PP7.1-00174 Active HIV reservoir in jejunum exhibit distinct phenotypic features and evoke innate cell redistribution	4
PP5.3 – 00166 Treatment with AZD5582 + het-IL15 transiently disrupts the reservoir establishment in SIV-infected macaques	4
8.4 – 00081 IL-15/IL-15RA Therapy Enhances Control of Viral Rebound in SIVInfected Macaques	4
Substantial uneven proliferation of CD4+ T cells during recovery from acute HIV infection is sufficient to explain the observed expanded clones in the HIV reservoir	4
PP 6.5 – 00205 Utilization of high-throughput assays and deep-learning for selection of CRISPR/Cas9-gRNA pairs used in an HIV-1 cure strategy	3
PP 1.26 – 00143 Understanding HIV transcription in Kaposi's sarcoma tumors during antiretroviral therapy	3
PP 3.20 – 00154 Epigenetic modifying compounds negatively impact viral replication within primary human macrophages	3
OP 1.4 – 00053 Definitive evidence of a persistent HIV reservoir in human brain myeloid cells despite ART	3
The HIV-2 OGH double reporter virus shows that HIV-2 is less cytotoxic and less sensitive to reactivation from latency than HIV-1 in cell culture	3
OP 3.6 – 00023 Effect of HIV-1 infection, viral particle production, and proviral integration site on CD4+ T cell proliferation	3
OP 4.8 – 00149 CD8+ T cells promote hiv latency in CD4+ T cells through the downmodulation of NF-kB	3
OP 4.3 – 00112 Leaky reservoirs are associated with HIV-specific cd4 and CD8 T-cell responses	3
Assessment of dengue virus threat to blood safety and community health: A single center study in northern Egypt	3
OP 3.8 – 00066 Characterization of the HIV-1 viral reservoir in subtype B early treated individuals	3
PP 1.27 – 00147 Role of the pol gene enhancer in HIV-1 transcription and replication in myeloid infected cells	3
Relatively high interest but limited active engagement in HIV cure research: Awareness, interest, and information-seeking among affected communities in the Netherlands	2
Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection	2
PP 1.11 – 00075 Selective nuclear retention of spliced and unspliced HIV-1 mRNAs following latency reversal	2
Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China	2
1.6 – 00161 HIV-1 Antisense Transcripts are frequent in FOXP3-negative Treglike cells expressing markers of persistence in vivo during acute HIV- 1 infection	2
PP 1.35 – 00172 A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV infected cells	2
PP2.3 – 00168 Blocks to HIV transcriptional initiation, elongation, and splicing contribute differentially to inefficient virus reactivation across authentic reservoir-harboring CD4+ T-cell clones	2
Editorial Board	2
Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV	2
Assessment of the general population knowledge about the emergence of Nipah virus outbreak in Bangladesh: A nationwide cross-sectional study	2
PP3.3 – 00121 Exploring the Effects of Benzodiazepines on a Novel Mechanism of Control in HIV-1 Infected Human Monocyte Derived Macrophages	2
PP 3.14 – 00190 Ex vivo response to latency reversal agents of CD4+ T cell subsets and monocyte derived HIV-1 subtype C LTR from individuals on suppressive cART	2
PP4.6 – 00115 Disruption of intestinal germinal centers during HIV infection	2
Heat shock protein: a double-edged sword linking innate immunity and hepatitis B virus infection	2
Editorial 10.4	2
Hepatitis C in Uganda: Identification of infected blood donors for micro-elimination	2
PP3.4 – 00100 Retinoids enhance NK effector functions against HIV infected CD4 T cells	2
OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab	1
PP2.2 – 00177 Late Increases in Intact Proviral DNA Reveal Variable HIV-1 Reservoir Dynamics	1
PP 4.10 – 00119 Multiomic dynamics of the cellular HIV reservoir after rebound during ATI	1
PP 2.15 – 00169 Macrophages are the primary source of virus in semen and male genital tract organs in acutely and chronically infected rhesus macaques	1
PP 1.34 – 00170 Intestinal endothelial cells substantially increase HIV infection and latency in resting and activated CD4+ T cells, particularly affecting CCR6+ Th17 subpopulation	1
Hepatitis B prevalence in an endemic area of hepatitis C virus: A population-based study implicated in hepatitis elimination in Thailand	1
PP7.2 – 00169 Longitudinal Persistence of HIV DNA in CSF Over 4 Years Despite Up to 20 Years of ART	1
PP 5.1 – 00045 Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Long-Acting Lenacapavir for Treatment of HIV	1
PP 2.11 – 00144 Transcriptional and translational SIV profiles of peripheral and lymphoid CD4+ T cells of viremic and ART-suppressed Rhesus macaques	1
PP 4.4 – 00059 Quantification of HIV Reservoirs in Brain: focus in bystander damage	1
Editorial Board	1
Hepatitis B birth dose vaccination for newborns in Uganda: A qualitative inquiry on pregnant women's perceptions, barriers and preferences	1
OP 3.2 – 00056 Clonally expanded HIV-1 proviruses with 5′-Leader defects can give rise to nonsuppressible residual viremia and complicate ART management	1
PP6.8 – 00062 Evaluating the Combination Effect of Autophagy Induction and CAR T Cell Therapy on “Kick-and-Kill” HIV Reservoir Depletion	1
8.5 – 00015 Changes in the composition of HIV-1 reservoir of PWH on ART and dasatinib	1
Editorial	1

OP 6.3 – 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia	1
OP 2.4 – 00145 No Evidence of Ongoing Viral Replication in SIV-Infected Macaques on Combination Antiretroviral Therapy Initiated in the Chronic Phase of Infection Despite Elevated Residual Plasma Vira	1
PP 3.12 – 00180 Distinct HIV-1 resistance profiles against bNAb in intact vs defective viral genomes	1
Editorial JVE 7.2	1
PP 3.4 – 00079 HIV-1 clade C reservoir characteristics in early and chronic treated infection	1
OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents	1
PP 1.41 – 00092 Spatial Transcriptomics and the Search for the Latent HIV-1 Cell Niche	1
Bringing social context into global biomedical HIV cure-related research: An urgent call to action	1
PP6.4 – 00096 Therapeutic efficacy of AAV-delivered HIV-1 bNAbs to prevent SHIV rebound in Rhesus macaques	1
High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era	1
PP 4.11 – 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption	1
PP 1.5 – 00040 Mapping of genetic interaction networks identifies a nucleosomal modification complex for silencing HIV	1
Editorial Board	1
PP3.1 – 00160 Macrophage Training Reactivates Latent HIV-1 from HAARTsuppressed PBMCs of PLWH	1
3.4 – 00150 Unbiased Genome-Wide CRISPR Screens in Primary Human CD4+ T Cells Identify Novel Proviral and Anti-viral HIV Host Factors	1
OP 4.4 – 00018 HIV reservoir burden associates with numbers of HIV-specific CD8+ T cells under long-term antiretroviral therapy and prevents them from differentiating into functional memory cells	1
4.5 – 00020 Control of HIV infection is associated with enhanced CD8T cell functionality during consecutive analytical treatment interruptions	1
PP 4.18 – 00213 Dynamics and antiviral role of TOX+ TCF1+ CD39+ CD8 T cells in lymphoid tissue of SIV-infected rhesus macaques	1
PP 1.21 – 00118 Regulation of HIV-1 persistence by the CARD8 inflammasome	1
PP5.5 – 00152 IL-15, Type I interferon, and amino acid pathways are correlated with SIV reservoir size and magnitude of viral rebound post-ATI in SIV-infected infant rhesus macaques	1
OP 6.6 – 00134 Viral Suppression in SHIV-infected Rhesus Macaques following AAVmediated Delivery of Closer-to-germline Monoclonal Antibodies	1
PP 4.21 – 00050 Seeding of long-lived HIV cellular reservoirs through differentiation of infected CCR5+CD4+ T cells into central memory cells	1
PP 7.2 – 00006 Acceptability of Home-Based Blood Collection Device for Viral Load Testing in HIV Cure Trials with Analytical Treatment Interruptions	1
OP 2.2 – 00200 Characterization of the SIV tissue reservoir transcriptional environment at the single focus level during ART and post ATI	1
PP5.10 – 00033 Ex vivo HIV DNA integration in STAT3 drives T cell persistence—A model of HIV-associated T cell lymphoma	1
To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials	1
OP 6.8 – 00102 In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-eCD4-Ig therapy	1
PP4.16 – 00014 Reduction of HIV-1 reservoir following mpox infection	1
PP 4.5 – 00064 Differentiation Enhances Reactivation of Latent HIV-1 Reservoir in CD4+ T Cells in PLWH With > 4 Years of Viral Suppression	1
PP 3.7 – 00128 Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes	1
PP7.3 – 00149 Ultra-sensitive secondary structure RNA quantification in the HIV Reservoir Assay Validation and Evaluation Network (RAVEN) using the BioSnap assay	1
Editorial JVE 9.4	1
Bypassing primary antiretroviral therapy centres in Sub-Saharan Africa: An integrative review of the theoretical and empirical literature	1
PP2.4 – 00157 Development of a Virology Quality Assurance Program to Assess Inter-lab Reproducibility of HIV-1 Reservoir Assays	1
The central nervous system is a potential reservoir and possible origin of drug resistance in hepatitis B infection	1
OP 1.1 Sequencing HIV: Significance and Impact	1
PP 4.27 – 00202 Single-cell RNA sequencing reveals CBD genetic signature in monocyte gene expression	1
Persistent HIV-1 transcription in CD4+ T cells from ART-suppressed individuals can originate from biologically competent proviruses	1
PP 1.30 – 00159 Dating HIV-1 reservoir formation in ARV-suppressed Ugandans	0
PP 1.18 – 00105 Machine learning identifies differentiating physicochemical signatures between HIV subtypes in Nef domains associated with host-cell regulation	0
Engagement of AKT and ERK signaling pathways facilitates infection of human neuronal cells with West Nile virus	0
1.1 – 00003 Longitudinal analysis in early treated individuals reveals alteration in the HIV-1 integration site landscape and composition of the inducible reservoir	0
OP 3.5 – 00152 HIV-1RNA+infected CD4 T cell burden in acute HIV-1 infection and association with inflammatory markers	0
PP 1.12 – 00076 The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11	0
6.4 – 00112 Overcoming immune responses directed toward AAV-delivered bNAbs	0
Editorial Board	0
PP4.17 – 00063 Distinct immune profiles in children living with HIV based on timing and duration of suppressive antiretroviral treatment Madeline	0
OP 7.3 – 00139 Pre-treatment Interruption Plasma Metabolites and Glycans Correlate with Time to HIV Rebound and Reservoir Size in ACTG A5345	0
PP 4.22 – 00087 Reversal of exhaustion of HIV-1-specific CTLs by CRISPR-mediated disruption of PD-1 gene	0
Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya	0
Highlights of the Conference on Retroviruses and Opportunistic Infections, 12–16 February 2022, virtual	0
Mass immunisation to eradicate Japanese encephalitis: Real-world evidence from Guizhou Province in 2005–2021	0
Editorial JVE 9.1	0
PP 4.23 – 00148 Inhibition of the GSK3 pathway enhances CD8+ T cell stemness and functional capacities without promoting non-cytolytic suppression of HIV transcription	0
7.3 – 00050 Profound reduction of HIV-1 reservoir cells over three decades of antiretroviral therapy started in early infancy	0
PP 1.7 – 00051 Continuous decline of intact proviral DNA after two decades of antiretroviral therapy	0
Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk	0
Antiviral activity of nitazoxanide against Morbillivirus infections	0
PP1.13 – 00083 The lysine methyltransferase SMYD5 methylates HIV-1 Tat K28/K29	0
OP 6.2 – 00195 Targeted genome engineering of human t cells in vivo for HIV cure	0
Information and communication are key for hepatitis B elimination in Francophone Africa: Insights from a survey among healthcare providers	0
From awareness to action: Unveiling knowledge, attitudes and testing strategies to enhance human papillomavirus vaccination uptake in Jordan	0
PP1.18 – 00043 Blockade of mA machinery in HIV latently infected primary CD4+ T cells enhances HIV-1 transcription, RNA export and protein translation, and sensitizes cells for apoptosis	0
PP4.11 – 00077 Long-term antiretroviral treatment reduces the reactivation capacity of HIV-1 reservoir	0
PP7.8 – 00085 Readiness for analytic treatment interruption trials among early treated children well-suppressed on antiretroviral therapy – willingness to participate, HIV-1 DNA levels and Western Blo	0
PP 1.15 – 00095 Proviruses persisting during the initial years of suppressive ART are relatively stable in terms of genetic diversity, clonal composition, and inferred integration date distribution	0
Key highlights from the international AIDS society (IAS) conference 2021	0
PP1.9 – 00102 Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors	0
PP 2.4 – 00038 Age and biological sex but not sex hormones influence IL-15 biological activity	0
PP 6.3 – 00178 Targeting the human and macaque CCR5 genes using the CRISPR-SaCas9 gene-editing platform	0
Bispecific antibody-derived molecules to target persistent HIV infection	0
OP 1.3 – 00017 The fraction of cells with unspliced HIV RNA is not associated with plasma viremia	0
2.6 – 00158 Doubling dolutegravir dosage reduces the viral reservoir in ARTtreated people with HIV	0
PP 1.17 – 00103 The Ubiquitin Ligase ITCH and CPSF6 Control HIV Transcription	0
4.3 – 00124 HIV infection induces T cell quiescence, leading to proviral latency	0
PP 1.1 – 00009 TB-associated microenvironment promotes HIV latency in CD4+ T cells	0
Identifying patterns of sexual behaviors and PrEP uptake characteristics among MSM who were eligible for PrEP: A national cross-section study	0
PP 7.3 – 00010 Virion Immunocapture Reveals Low-level Myeloid-derived HIV Expression in Semen under INSTI-based Therapy is Disparate from Circulating Seminal and Blood Proviral Sequences	0
Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2	0
PP 4.12 – 00141 Enhancement of IL15/IL15RA signaling in immune cells using CRISPR-dCas9-VPR platform	0

PP1.2 – 00165 Inhibition of ARP2/3 by HIV Nef Leads to Impaired CD4+ T Cell Function & Dysregulation of Immunity within Progressors but not all HIV Controllers	0
PP 6.4 – 00203 Construct a series of universal gRNAs targeting various regions within HIV	0
PP8.4 – 00154 Using Immunomodulatory Drug Pretreatment to Enhance AAV Delivery of Anti-HIV Broadly Neutralizing Monoclonal Antibodies	0
PP4.12 – 00068 Persistence and Maturation of B Cell Lineages during ART initiation in Chronic SHIV-infected Juvenile Rhesus Macaques	0
Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy	0
PP 7.11 – 00091 In vivo and in vitro imaging of viral reservoirs to understand bystander damage during chronic HIV infection	0
World AIDS Conference 2022 – updates on antiretroviral therapy	0
PP3.6 – 00064 Novel synthesized protein kinase C modulators show enhanced HIV latency reversal properties and synergize with a BET bromodomain inhibitor	0
PP 1.40 – 00074 Blood Brain Barrier Pericytes and the Molecular Impact of Active and Latent HIV Infection	0
PP 4.15 – 00181 Distinctive cytoskeletal properties are implicated in the resistance of a fraction of productively HIV-infected CD4+ T-cells to killing by cytotoxic T lymphocytes (CTL)	0
OP 2.1 CCR5 in HIV Prevention and Cure	0
PP2.6 – 00048 The HIV reservoir can be established in either quiescent or senescent CD4 T cells	0
Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa	0
PP1.10 – 00098 Gene expression dynamics following dasatinib treatment and discontinuation in people with HIV-1: case report	0
PP 3.5 – 00110 The proviral quasispecies of HIV-1	0
PP 5.6 – 00183 Combination of traditional medicine product (SDK-2) with TNF-α synergistically reactivate latent HIV-1 subtype C in vitro	0
PP4.1 – 00179 Distinct Immunity Signatures Uncover Diverse Profiles Among Elite HIV Controllers	0
PP 7.12 – 00192 The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection	0
Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV	0
PP8.8 – 00060 Efficacy of HIV suppression by AAV-bNAb therapy is determined by antibody escapability	0
6.6 – 00176 CAR/CCR9 T cell immunotherapy shows promise in localization of SIV-specific CAR T cells to the gastrointestinal tract of rhesus macaques	0
7.1 – 00113 Safety and PD-1 receptor occupancy with low dose Nivolumab in adults living with HIV on antiretroviral therapy: NIVO-LD	0
PP 3.15 – 00207 A polyvalent HIV-1 virus-like particle formulation drives the majority of the infectious HIV-1 reservoir out of latency within CD4+ T cells of individuals receiving cART during chronic	0
Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country	0
PP4.13 – 00012 Distinct CD4 tissue-resident memory (TRM) depletion and CD8 TRM function between the small and large intestine indicate regionspecific mechanisms for gut pathology in people with HIV (P	0
1.3 – 00084 Persistence of HIV genomes in bacteria-specific CD4+ T cells during ART	0
Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies	0
PP 4.6 – 00065 Retinoic Acid Transcriptionally Reprograms Macrophages for Increased Permissiveness to HIV-1 Replication	0
Knowledge and attitude among Bangladeshi healthcare workers regarding the management and infection prevention and control of Nipah virus	0
4.1 – 00057 Tissue resident memory programs of intestinal CD4+ and CD8+ T cells facilitate HIV-1 persistence	0
PP2.7 – 00034 The Cross-Subtype Intact Proviral DNA Assay Detects >97% of Proviral Sequences from Diverse HIV Clades	0
5.2 – 00120 Well-seeded reservoirs in gut are associated with tertiary lymphoid organs and stress response activation	0
PP 1.39 – 00086 The level of cell activation is associated with the pre-integrative latency of HIV linear DNA	0
ST1.4 – 00008 Persistent HIV-1 unintegrated linear DNA can integrate and lead to viral replication after integrase inhibitor treatment removal	0
3.3 – 00093 RasGRP1 agonists induce cyclin T1 translation to reverse HIV-1 latency in primary CD4+ T cells	0
PP 2.2 – 00024 Evaluation of an NNRTI-mediated Targeted Activated Cell Kill (TACK) in a Viremic Mouse Model	0
OP 1.9 – 00042 Measuring the impact of early 3BNC117 intervention at ART initiation on the productive reservoir in a cohort of diverse viral subtypes: results from the VIP-SPOT assay in the eCLEAR tri	0
Highlights of the first edition of the European Conference on Microbiota & Virology: A hybrid event, Paris, 23 March 2023	0
OP 3.4 – 00197 Infected naïve CD4+ T cells in children with HIV can proliferate and persist on ART	0
OP 4.7 – 00121 Circulating immune predictors of intact HIV reservoir decay during long-term ART	0
Editorial Board	0
PP 4.19 – 00021 Impact of SARS-COV-2-Mediated CD4 T Cell Activation HIV DNA Persistence In Vivo	0
PP 1.44 – 00107 Longitudinal evaluation of epigenetic age among people living with HIV (PLWH) undergoing multimodal curative interventions	0
PP 8.10 – 00155 Evaluation of HIV-specific T cell response in BEAT2 clinical trial	0
PP 8.4 – 00061 Bispecific antibodies promote natural killer cell-mediated elimination of the HIV reservoir	0
PP8.1 – 00046 Safety, Viral Resuppression Dynamics, and Immunological Signatures of a PD-1 Inhibitor, Budigalimab, Among PWH During Analytical Treatment Interruption: Phase 1 Randomized Double- Blind	0
PP5.7 – 00047 Assessing the Impact of Macrophage-Tropism on Fitness of SHIV in vivo	0
HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption	0
PP 1.32 – 00163 cGAS/STING Signaling Drives HIV-1 Replication in Acutely Infected Macrophages	0
OP 2.6 – 00135 Constitutive NKG2A levels and timing of antiretroviral therapy initiation impact the potential role of NK cells after treatment interruption - the pVISCONTI study	0
PP8.3 – 00167 Exploring Strategies to Enhance ADCC of HIV-infected cells by targeting the CD16 receptor	0
PP 4.25 – 00196 The Role of Epigenetics in Mediating Neuronal Circuitry and Maladaptive Neuronal Changes in HIV and Opioid Drug Addiction	0
PP 2.7 – 00093 Modeling HIV-1 Pathogenesis and Latency in iPSC-Derived Human Cerebral Organoids	0
Incentivized self-vaccination for global measles eradication	0
4.2 – 00027 Secondary cytotoxicity of memory CD8+ T cells targeting autologous HIV during treated chronic infection is associated with suppression of provirus and of recrudescent viremia	0
A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs	0
PP5.9 – 00108 Tracking infected cell fate using a barcoded virus	0
OP 5.4 – 00127 Identification and characterization of novel inhibitors of HIV Tat protein	0
PP 4.14 – 00173 Antiretroviral therapy repairs CD4 T cell dysregulation in people living with HIV	0
Genetic characterization on the nucleoprotein and fusion gene of wild-type measles virus circulating in Shanghai, 2001–2022	0
PP1.20 – 00032 A chemical screen of chromatin targeting compounds identifies TAF1 as a novel regulator of HIV latency	0
6.5 – 00173 A single-infusion of CCR5 modified stem-like CD4 T cells to limit HIV/SIV persistence during ART and promote control of viremia upon ATI	0
5.4 – 00148 Targeting Wnt/β-catenin signaling pathway during latency reversal in ART-suppressed SIV-infected rhesus macaques	0
PP 4.16 – 00188 Investigating the Role of Naïve CD4+ T-cells as a CTL Resistant Sanctuary for Intact HIV Proviruses	0
PP7.6 – 00039 Elevated Lymph Node Metabolic Activity During Long-Term Effective Anti-Retroviral Therapy	0
PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART	0
Menopause care in women living with HIV in the UK - A review	0
Editorial Board	0
Disclaimer	0
8.6 – 00097 Increased HIV-1 proviral reactivation and reservoir size in people with HIV on anticancer treatment	0
PP 4.20 – 00025 A Metabolic Approach to Eradicate HIV brain viral reservoirs	0
OP 7.4 – 00012 Series of Jojo. A way to disseminate HIV Cure information in a community language	0
PP1.1 – 00164 Nuclear retention of unspliced HIV-1 RNA as a novel reversible posttranscriptional block in latency	0
Knowledge and willingness towards human Papillomavirus vaccination among the parents and school teachers of eligible girls in Dhaka, Bangladesh: A school-based cross-sectional study	0
PP 4.8 – 00108 Presentation of cognate antigens by dendritic cells causes stochastic HIV expression	0
Influenza A (H6N6) viruses isolated from chickens replicate in mice and human lungs without prior adaptation	0
OP 1.5 – 00046 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment	0
PP 7.9 – 00073 HIV-1 Cell-Associated RNA Provides 0.8 Prediction Accuracy for Time to Rebound after Treatment Interruption	0
2.2 – 00058 Role of HIV integration site on clonal expansion of infected cells and maintenance of latency in vivo	0
Vaccination with inactivated virus against low pathogenic avian influenza subtype H9N2 does not prevent virus transmission in chickens	0
PP 3.19 – 00062 The Role of Pannexin-1 channels in HIV infection and persistence	0
PP1.12 – 00061 Nanopore sequencing enables capturing of long HIV-1 reads for multi-omic analysis of HIV-1-infected cells	0
Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir	0
PP 1.3 – 00022 Signaling pathways that activate P-TEFb to reverse HIV latency in CD4+ T cells	0
Highlights from the 30th Conference on Retroviruses and Opportunist Infections (CROI)	0
OP 7.2 – 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: four cases from the open label arm of the RIO trial	0
7.6 – 00052 The Tuberculosis Associated Microenvironment Reduces CD8+ TCell Control of HIV at the Site of the Coinfection	0
Phylogenetic signature and prevalence of natural resistance-associated substitutions for hepatitis C virus genotypes 3a and 3b in southwestern China	0
Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients	0
OP 3.7 – 00099 Cohort-specific Adaptation of the Intact Proviral DNA Assay (IPDA) to HIV-1 subtypes A1, D, and recombinants	0
Study on immune persistence of the CTN-1V strain rabies vaccine in humans	0
PP 1.8 – 00054 Integrative epigenomic and transcriptomic analysis reveals distinct regulations of mRNAs and lncRNAs in active versus latent HIV-1 infection of T cells	0
PP 3.2 – 00068 Differential transcriptional levels of HIV-1 near full-length and highly deleted proviruses	0
PP 8.9 – 00142 Safety and activity of BCL-2 inhibitor Venetoclax in uninfected rhesus macaques	0
Combination of dasabuvir and PSI-6206 for the treatment of coxsackievirus B3 infection	0